This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Kelley, Robin
| Item Type | Name |
|
Concept
|
Receptors, Fibroblast Growth Factor
|
|
Concept
|
Receptor, Fibroblast Growth Factor, Type 1
|
|
Concept
|
Receptor, Fibroblast Growth Factor, Type 2
|
|
Academic Article
|
Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling.
|
|
Academic Article
|
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
|
|
Academic Article
|
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF/FGFR Aberrations: A Phase I Dose-Expansion Study.
|
|
Academic Article
|
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
|
|
Academic Article
|
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.
|
|
Academic Article
|
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
|
|
Academic Article
|
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer.
|
|
Academic Article
|
Cataracts Associated With Fibroblast Growth Factor Receptor Inhibitors for Cholangiocarcinoma.
|
|
Academic Article
|
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma.
|
- Fibroblast Growth Factor 7